Eliot S. Jubelirer, Schiff Hardin LLP
Eliot Jubelirer is a partner with Schiff Hardin LLP. He has varied and extensive experience in: toxic tort and product liability litigation; commercial litigation; legal malpractice litigation; and construction defect cases. He has tried numerous jury trials, court trials, and arbitrations to verdict. Mr. Jubelirer has successfully briefed and argued appeals in the U.S. Courts of Appeals for the Ninth and Sixth Circuits on behalf of an international shipping company, and numerous cases in California appellate courts on behalf of a variety of clients. One of his petitions to the California Supreme Court was featured in an article in the American Bar Association Journal. He is an adviser on a national level on toxic tort issues for clients involved in mass tort litigation. His practice includes construction and commercial litigation at the trial court and appellate levels. Mr. Jubelirer is a nationally recognized speaker on toxic torts, occupational lung injuries, and asbestos litigation.

Mr. Jubelirer earned a J.D. from the University of California, Berkeley, School of Law, where he was a member of the Order of the Coif and served as Research Editor for the California Law Review, and a B.A., with honors, from the University of Wisconsin — Madison, where he was Phi Beta Kappa.

Barrett Naman, The Nemeroff Law Firm
Mr. Naman dedicates his practice to working for victims of injustice and fighting corporate entities that value profits over the health and safety of people. It is his belief that all victims deserve the best and most focused representation that drives him to aggressively fight for his clients. He has worked to achieve substantial verdicts and settlements for his clients in jurisdictions throughout the country. In recognition of the quality of his work, Mr. Naman was named as a “Rising Star” in the Super Lawyers edition of Texas Monthly, a distinction reserved for the top 2.5% of Texas attorneys who are under 40 years of age or have been practicing less than 10 years.

Mr. Naman earned a J.D. from Texas Tech University School of Law and a B.A. from the University of Texas at Austin.

Hedy Lee Kindler, M.D., Director, Mesothelioma Program, The University of Chicago
Hedy Lee Kindler, M.D., is an internationally recognized cancer expert who specializes in the medical treatment of pancreatic cancer, gastrointestinal stromal tumors, and malignant mesothelioma. Her research focuses on the investigation of novel agents for the treatment of these cancers, and she designs and leads many innovative clinical trials for patients with these diseases.

Dr. Kindler is an associate editor of Lung Cancer and has published numerous journal articles, review articles, book chapters, and abstracts. A popular speaker, she has been invited to lecture at hundreds of scientific meetings around the world.

Dr. Kindler is the immediate past-president of the International Mesothelioma Interest Group and is an active member of several committees and boards, including the Science Advisory Board of the Mesothelioma Foundation, the NCI Pancreatic Cancer Task Force, and the Alliance for Clinical Trials in Oncology. She attended medical school at the State University of New York, Buffalo and performed an internship and residency at the University of California at Los Angeles Medical Center.